# EDGAR Filing Document

**Accession Number:** 0002030763
**File Stem:** 0001493152-26-005387
**Filing Date:** 2026-2
**Character Count:** 7298
**Document Hash:** 1b625b8161343037cc92cd3c02cc0967
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-005387.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0001493152-26-005387

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20260201

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260205

**DATE AS OF CHANGE**: 20260205

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Wellgistics Health, Inc.
- **CENTRAL INDEX KEY:** 0002030763
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 933264234
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42530
- **FILM NUMBER:** 26604170

**BUSINESS ADDRESS:**
- **STREET 1:** 3000 BAYPORT DRIVE SUITE 950
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** 1-843-302-1785

**MAIL ADDRESS:**
- **STREET 1:** 3000 BAYPORT DRIVE SUITE 950
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Danam Health, Inc
- **DATE OF NAME CHANGE:** 20240717

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): **February 1, 2026**

**WELLGISTICS HEALTH, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-42530** | **93-3264234** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**3000 Bayport Drive**

**Suite 950**

**Tampa, FL 33607**

(Address of principal executive offices, including zip code)

Registrant's telephone number, including area code: **(844) 203-6092**

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.0001 par value per share | WGRX | The Nasdaq Capital Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

***Director Resignations***

On February 1, 2026, Steven Lee advised the Company that he was resigning from his position as a member of the board of directors effective immediately. Mr. Lee indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices. At the time of his resignation, Mr. Lee served on the Ethics Committee.

On February 1, 2026, Howard Doss advised the Company that he was resigning from his position as a member of the board of directors effective immediately. Mr. Doss indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices. At the time of his resignation, Mr. Doss served as chairman on the Audit Committee.

**Item 9.01. Financial Statements and Exhibits.**

*(d) Exhibits.*

 

The following exhibits are filed as part of, or incorporated by reference into, this Report.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| **17.1** | [Director Resignation Letter of Steven Lee dated as of February 1, 2026](ex17-1.htm) |
| **17.2** | [Director Resignation Letter of Howard Doss dated as of February 1, 2026](ex17-2.htm) |
| **104\*** | Cover Page Interactive Data File (formatted as Inline XBRL) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: February 5, 2026 | **WELLGISTICS HEALTH, INC.** | **WELLGISTICS HEALTH, INC.** |
|  | By: | */s/ Prashant Patel* |
|  |  | Prashant Patel, President |

---

## Exhibit 17.1

**Exhibit 17.1**

**Board Resignation** 

VIA EMAIL

WELLGISTICS HEALTH, INC.

3000 Bayport Drive

Suite 950

Tampa, FL 33607

Re: Resignation from the Board of Directors

Dear Mr. Ajjarapu, Chairman of the Board:

As discussed, I hereby resign from my position as a member of the Board of Directors (the "Board") of Wellgistics Health, Inc, (the" Company") and from any committees of the Board on which I serve, including the Governance Committee, effective immediately.

My resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.

I appreciate the opportunity to have served the Company, and I am grateful to my fellow directors and the management team for their time and collaboration.

Please confirm receipt of this resignation.

Sincerely,

Steven D. Lee

Cc: Members of the Board, Management, and Legal Counsel

## Exhibit 17.2

**Exhibit 17.2**

DELIVERED VIA EMAIL

February 1, 2026

Wellgistics Health, Inc.

3000 Bayport Drive, Suite 950

Tampa, FL 33607

Re: Resignation from Board of Directors and Committees

Dear Mr. Ajjarapu, Chairman of the Board:

I hereby resign from the Board of Directors of Wellgistics Health, Inc., and from the Audit and Compensation Committees of the Board, effective immediately.

My resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices.

I appreciate the opportunity to have served the Company and value the professionalism and dedication of my fellow directors and the management team.

Please confirm receipt of this resignation.

Best Regards,

Howard Doss

Cc: Board Members, Management and Legal Counsel